Partial to complete abrogation of the subepithelial macrophage barrier against the gut microbiota in patients with ulcerative colitis and Crohn's colitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|72|4|580-587

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.72, Iss.4, 2018-03, pp. : 580-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1405-1406

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vedolizumab for ulcerative colitis and Crohn's disease

By  

PRESCRIBER, Vol. 26, Iss. 10, 2015-05 ,pp. : 22-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

Population pharmacokinetics‐pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 2, 2015-07 ,pp. : 188-202

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: the effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1406-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Crohn disease and colitis in children

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 3, 2015-03 ,pp. : 266-270

John Wiley & Sons Inc

Access to resources Recommend Favorite